{
"info": {
"nct_id": "NCT00716794",
"official_title": "A Phase I/II, Open-Label, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Potential Activity of HE3235 When Administered Orally to Patients With Prostate Cancer",
"inclusion_criteria": "* Patient is male and at least 18 years of age, at the time of screening;\n* Patient has metastatic disease (any T, any N, M1);\n* Patient has failed at least 1 taxane regimen; or Patient has symptomatic or asymptomatic CRPC and is chemotherapy-naïve\n* Patient has histologically or cytologically confirmed adenocarcinoma of the prostate;\n* Patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:\n\n * PSA level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.\n * Evaluable disease progression by modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria;\n * Progression of metastatic bone disease on bone scan with > 2 new lesions\n* Patient has ECOG (Eastern Cooperative Oncology Group) performance status of 0-2;\n\nMain\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation Treated epidural disease is allowed\n* Patient has active infection;\n* Patient having a history of clinically significant cardiovascular disease (such as CHF), clinically significant hepatic, respiratory or renal abnormalities;\n* Patient who has any clinically significant abnormalities in laboratory results at screening\n* Patient who has a history of clinically significant neurological or psychiatric condition;\n\nAdditional criteria are applicable to expansion cohorts.",
"miscellaneous_criteria": "Main"
},
"inclusion_lines": [
{
"line": "* Patient is male and at least 18 years of age, at the time of screening;",
"criterions": [
{
"exact_snippets": "Patient is male",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "male"
}
]
},
{
"exact_snippets": "at least 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patient has metastatic disease (any T, any N, M1);",
"criterions": [
{
"exact_snippets": "metastatic disease (any T, any N, M1)",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has failed at least 1 taxane regimen; or Patient has symptomatic or asymptomatic CRPC and is chemotherapy-naïve",
"criterions": [
{
"exact_snippets": "Patient has failed at least 1 taxane regimen",
"criterion": "taxane regimen",
"requirements": [
{
"requirement_type": "failure",
"expected_value": true
},
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "regimen"
}
}
]
},
{
"exact_snippets": "Patient has symptomatic or asymptomatic CRPC",
"criterion": "CRPC",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "symptom status",
"expected_value": [
"symptomatic",
"asymptomatic"
]
}
]
},
{
"exact_snippets": "Patient ... is chemotherapy-naïve",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "naivety",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has histologically or cytologically confirmed adenocarcinoma of the prostate;",
"criterions": [
{
"exact_snippets": "histologically or cytologically confirmed adenocarcinoma of the prostate",
"criterion": "adenocarcinoma of the prostate",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "* Patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:",
"criterions": [
{
"exact_snippets": "progression of disease",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "adequate hormone therapy",
"criterion": "hormone therapy adequacy",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* PSA level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.",
"criterions": [
{
"exact_snippets": "PSA level of at least 2 ng/ml",
"criterion": "PSA level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "ng/ml"
}
}
]
},
{
"exact_snippets": "risen on at least 2 successive occasions, at least 1 week apart",
"criterion": "PSA level rise",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "occasions"
}
},
{
"requirement_type": "interval",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "week"
}
}
]
}
]
},
{
"line": "* Evaluable disease progression by modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria;",
"criterions": [
{
"exact_snippets": "Evaluable disease progression by modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "evaluation method",
"expected_value": "modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria"
}
]
}
]
},
{
"line": "* Progression of metastatic bone disease on bone scan with > 2 new lesions",
"criterions": [
{
"exact_snippets": "Progression of metastatic bone disease on bone scan",
"criterion": "metastatic bone disease",
"requirements": [
{
"requirement_type": "progression",
"expected_value": true
}
]
},
{
"exact_snippets": "... > 2 new lesions",
"criterion": "new lesions",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "lesions"
}
}
]
}
]
},
{
"line": "* Patient has ECOG (Eastern Cooperative Oncology Group) performance status of 0-2;",
"criterions": [
{
"exact_snippets": "ECOG (Eastern Cooperative Oncology Group) performance status of 0-2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation Treated epidural disease is allowed",
"criterions": [
{
"exact_snippets": "Patient has symptomatic parenchymal brain metastases",
"criterion": "parenchymal brain metastases",
"requirements": [
{
"requirement_type": "symptomatic",
"expected_value": true
}
]
},
{
"exact_snippets": "active epidural disease requiring whole-brain irradiation",
"criterion": "epidural disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
},
{
"requirement_type": "treatment requirement",
"expected_value": "requiring whole-brain irradiation"
}
]
},
{
"exact_snippets": "Treated epidural disease is allowed",
"criterion": "epidural disease",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "treated"
}
]
}
]
},
{
"line": "* Patient has active infection;",
"criterions": [
{
"exact_snippets": "Patient has active infection",
"criterion": "active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient having a history of clinically significant cardiovascular disease (such as CHF), clinically significant hepatic, respiratory or renal abnormalities;",
"criterions": [
{
"exact_snippets": "history of clinically significant cardiovascular disease",
"criterion": "cardiovascular disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "significance",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "clinically significant hepatic ... abnormalities",
"criterion": "hepatic abnormalities",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "clinically significant ... respiratory ... abnormalities",
"criterion": "respiratory abnormalities",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "clinically significant ... renal abnormalities",
"criterion": "renal abnormalities",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Patient who has any clinically significant abnormalities in laboratory results at screening",
"criterions": [
{
"exact_snippets": "clinically significant abnormalities in laboratory results",
"criterion": "laboratory results",
"requirements": [
{
"requirement_type": "abnormalities",
"expected_value": true
},
{
"requirement_type": "clinical significance",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient who has a history of clinically significant neurological or psychiatric condition;",
"criterions": [
{
"exact_snippets": "history of clinically significant neurological ... condition",
"criterion": "neurological condition",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "clinical significance",
"expected_value": true
}
]
},
{
"exact_snippets": "history of clinically significant ... psychiatric condition",
"criterion": "psychiatric condition",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "clinical significance",
"expected_value": true
}
]
}
]
},
{
"line": "Additional criteria are applicable to expansion cohorts.",
"criterions": [
{
"exact_snippets": "expansion cohorts",
"criterion": "expansion cohorts",
"requirements": [
{
"requirement_type": "applicability",
"expected_value": "additional criteria"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Main",
"criterions": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "> 2 cm in diameter",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Main",
"criterions": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "> 2 cm in diameter",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
]
}
]
}
]
}